News zum Sektor Gesundheit aus Neuseeland

 

Find insight on Novo Nordisk, Ramsay Health Care and Fisher & Paykel in the latest Market Talks covering Health Care....

WELLINGTON (dpa-AFX) - Ryman Healthcare Ltd. (RYM.NZ), a retirement village and rest home operator, on Thursday reported loss in the first half compared with the previous year. For the half of the......

Find insight on Novo Nordisk, Ramsay Health Care and Fisher & Paykel in the latest Market Talks covering Health Care....

WELLINGTON (dpa-AFX) - Fisher & Paykel Healthcare Corp. Ltd. (FSPKF, FPH.AX), on Wednesday reported its profit increased in the first half of fiscal year 2025 compared with the previous year. For ......

The market's response was in appreciation of strong results and upgraded guidance The post Fisher & Paykel shares surge 8% on half-year results appeared first on The Motley Fool Australia....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Analysts have given their verdicts on these shares. The post Should you buy Mesoblast, Paladin Energy, and Xero shares? appeared first on The Motley Fool Australia....

These shares are ending the week in the red. But why? The post Why Rox Resources, Telix, TPG Telecom, and Xero shares are dropping today appeared first on The Motley Fool Australia....

Neuren Pharmaceuticals shares have exploded recently. The post Macquarie predicts 12% upside for this ASX 200 healthcare stock appeared first on The Motley Fool Australia....

With more than seven million users on the HotCopper forums, every discussion and speculation…...

Neuren Pharmaceuticals reported record DAYBUE sales and royalties in Q3 2025, with expanding US and international demand. The post Neuren Pharmaceuticals Q3 2025: Record DAYBUE sales fuel robust growth appeared first on The Motley Fool Australia....

These shares are starting the week positively. But why? The post Why DroneShield, Larvotto, Neuren, and Zip shares are rising today appeared first on The Motley Fool Australia....

Neuren Pharmaceuticals shares are in focus after the FDA granted Fast Track to its NNZ-2591 treatment for Phelan-McDermid syndrome. The post Neuren Pharmaceuticals earns FDA Fast Track for NNZ-2591 in PMS appeared first on The Motley Fool Australia....

Synlait Milk will sell several of its New Zealand assets to Abbott Laboratories for NZ$307 million ($177 million), enabling it to reset its balance sheet after a period of losses and underperformance....

The ASX will welcome the $2.1 billion Ryman Healthcare to the bourse next week. The post New Zealand's largest retirement living provider to list on the ASX next week appeared first on The Motley Fool Australia....

The ASX 200 is surging on Friday after new records were set on Wall Street last night. The post Life360 and Neuren Pharmaceuticals among 9 ASX 200 shares hitting multi-year highs appeared first on The Motley Fool Australia....

Welcome to HotCopper's Director Trades column, where we take a look at all the…...

These shares are falling more than most today. But why? The post Why 4DMedical, BlueScope, EOS, and Spark NZ shares are falling today appeared first on The Motley Fool Australia....

These shares are ending the week with a bang. But why? The post Why 4DMedical, Lotus Resources, Vulcan Energy, and Xero shares are storming higher today appeared first on The Motley Fool Australia....

These shares are having a strong session on Thursday. But why? The post Why EOS, Eroad, Neuren, and Westgold shares are roaring higher today appeared first on The Motley Fool Australia....